We also observed positive correlations between the risk score and several immune checkpoint genes, including SIGLEC7, PDCD1, LILRB2, HAVCR2, and LAG3, which have been tied to poor prognosis in glioma (27). This evidence concerns the gene HAVCR2 and central nervous system cancer.